| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/13/2009 | DE102008007440A1 Aminosäurederivate als Arzneistoffe Amino acid derivatives as drugs |
| 08/13/2009 | DE102008007381A1 Amidine und Guanidine und deren Derivate zur Behandlung von Krankheiten Amidines and guanidines and their derivatives for the treatment of diseases |
| 08/13/2009 | DE102008007198A1 Oral oder nasal applizierbare Epinephrin- haltige Zubereitungen mit verbesserten Eigenschaften Orally or nasally administered epinephrine-containing formulations with improved properties |
| 08/13/2009 | CA2715143A1 Novel phenylpyrrole derivative |
| 08/13/2009 | CA2714972A1 Use of p27kip1 for the prevention and treatment of heart failure |
| 08/13/2009 | CA2714480A1 3,8-diaminotetrahydroquinoline derivative |
| 08/13/2009 | CA2714350A1 Substituted piperidines as renin inhibitors |
| 08/13/2009 | CA2714347A1 Substituted piperidines as renin inhibitors |
| 08/13/2009 | CA2713768A1 Substituted furans and use thereof |
| 08/13/2009 | CA2713377A1 Protective effect of high dose folate on mycardial ischemia |
| 08/13/2009 | CA2711399A1 3-substituted sulfonylpiperidine derivative |
| 08/13/2009 | CA2706082A1 Nitric oxide donor compounds |
| 08/12/2009 | EP2087903A1 Extract powder of indigo-containing plant, method for production thereof, and use thereof |
| 08/12/2009 | EP2087891A2 Pharmaceutical compositions for treating lymphoma |
| 08/12/2009 | EP2087890A1 Sustained release preparation for tissue regeneration therapy |
| 08/12/2009 | EP2087888A1 Adenosine a1 receptor antagonists for the treatment of alkalosis |
| 08/12/2009 | EP2087887A1 Highly absorbable composition for oral administration containing oxidized coenzyme q10 |
| 08/12/2009 | EP2086970A2 2-(pyrazin-2-yl)-thiazole and 2-(1h pyrazol-3-yl)-thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and other disorders |
| 08/12/2009 | EP2086969A1 3-cyano-5-thiazaheteroaryl-dihydropyridine and the use thereof for the treatment of cardiovascular diseases |
| 08/12/2009 | EP2086962A1 (r) -5-methyl-4, 5-dihydro- pyrazole-1, 5-dicarboxylic acid 1- [( 4 -chlorophenyl) amide 5-{ [2-fluoro-4- (2-oxo-2h-pyridin-1-yl) -phenyl]amide) as a factor xa inhibitor |
| 08/12/2009 | EP2086587A2 Use of a fusion protein between a cytokine and an antibody targeting the ed-b fibronectin domain for the treatment of atherosclerosis |
| 08/12/2009 | EP2086558A2 Ph 1b toxin, cdna of ph 1 b toxin gene, pharmaceutical compositions containing ph 1b toxin, processes for their obtention and product |
| 08/12/2009 | EP2086556A2 Mixed cell populations for tissue repair and separation technique for cell processing |
| 08/12/2009 | EP2086543A2 Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same |
| 08/12/2009 | EP2086537A1 Imidazo[2, 1-b]thiazoles and their use as pharmaceuticals |
| 08/12/2009 | EP2086535A2 Angiotensin ii receptor antagonist for the treatment of systemic diseases in cats |
| 08/12/2009 | EP2086533A2 Use of an adenosine antagonist |
| 08/12/2009 | EP1832296B1 Compositions based on Midkine for the treatment of chronic stage injury of the heart after ischemia/reperfusion |
| 08/12/2009 | EP1819355A4 Methods of using chimeric coiled-coil molecule |
| 08/12/2009 | EP1636221B1 3-Heterocyclyl-Azetidine compounds useful as NK1/NK2 receptors antagonists |
| 08/12/2009 | EP1567150B1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 08/12/2009 | EP1463735B1 Imidazo¬2,1-b -1,3,4-thiadiazole sulfonamides |
| 08/12/2009 | EP1427415B1 Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 08/12/2009 | EP1409645B1 Probiotic lactobacillus salivarius strains |
| 08/12/2009 | EP1385514B9 Spiroindene and spiroindane compounds |
| 08/12/2009 | EP1379257B1 Prodrugs of anticancer agents employing substituted aromatic acids |
| 08/12/2009 | EP1290227B1 Compositions, kits, and methods for identification and modulation of type i diabetes |
| 08/12/2009 | EP1274319B1 Compositions and methods for improving vascular health |
| 08/12/2009 | EP1224170B1 6-position substituted indoline, production and use thereof as a medicament |
| 08/12/2009 | EP1198589B9 Tenascin-c nucleic acid ligands |
| 08/12/2009 | EP1149111B1 Method and composition for angiogenesis inhibition |
| 08/12/2009 | CN101506355A Multipotential expanded mesenchymal precursor cell progeny (MEMP) and uses thereof |
| 08/12/2009 | CN101506225A Cardioprotective compounds |
| 08/12/2009 | CN101506216A Fused imidazole derivatives for the treatment of disorders mediated by aldosterone synthase and/or 11-beta-hydroxylase and/or aromatase |
| 08/12/2009 | CN101506203A 2- (pyrazin-2-yl) -thiazole and 2- (1h-pyraz0l-3-yl) -thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and o |
| 08/12/2009 | CN101506177A 2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as JAK kinases inhibitors |
| 08/12/2009 | CN101506175A 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase C-alpha |
| 08/12/2009 | CN101506171A Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 08/12/2009 | CN101506158A Novel 6-5 bicycic heterocyclic derivative and medical use thereof |
| 08/12/2009 | CN101505785A Use of tenecteplase for treating acute ischemic stroke |
| 08/12/2009 | CN101505757A Drug combinations for treating airway diseases |
| 08/12/2009 | CN101503736A Use of retinoic acid induced gene I, signal pathway mediated by coding protein thereof |
| 08/12/2009 | CN101503458A Small molecule polypeptide for preventing and treating angiogenesis and use thereof |
| 08/12/2009 | CN101503369A Method for preparing vanillyl acidamide compounds by interfacial reaction |
| 08/12/2009 | CN101503341A Novel technique for preparing schizandrol A and schizandrol B |
| 08/12/2009 | CN101502659A Novel use of Kruppel-like transcription factor 4 |
| 08/12/2009 | CN101502635A Medicament composition containing Reserpine |
| 08/12/2009 | CN101502621A Nutrient solution for cleaning blood and softening blood vessel |
| 08/12/2009 | CN101502610A Method for extracting veratrum alkaloid from Veratrum nigrum by supercritical carbon dioxide |
| 08/12/2009 | CN101502585A Chinese red pepper plant extract as well as preparation method and application thereof |
| 08/12/2009 | CN101502559A Method for continuously extracting effective ingredients from Semen cassiae under high pressure |
| 08/12/2009 | CN101502558A Method for preparing astragalus total saponin injection from cyclodextrin composition |
| 08/12/2009 | CN101502556A Cardiac and cerebral vascular disease treating medicine composition |
| 08/12/2009 | CN101502549A Notoginsen triterpenes capsule as well as preparation method thereof and method for measuring content |
| 08/12/2009 | CN101502541A Styrax plant and use of extract thereof |
| 08/12/2009 | CN101502539A Method for preparing ginkgo leaf extract cyclodextrin inclusion compound and preparation |
| 08/12/2009 | CN101502536A Cedar total flavone as well as preparation method and medical use |
| 08/12/2009 | CN101502530A Medicament composition containing ginseng saponin and periplocin and uses thereof |
| 08/12/2009 | CN101502507A Egonol type benzofuran and novel use in pharmacy of glycosides thereof |
| 08/12/2009 | CN101502505A N-acetylcysteine compound medicinal preparation for treating atherosclerosis |
| 08/12/2009 | CN101502502A Medicament composition for preventing and treating ischemia-reperfusion injury of kidney |
| 08/12/2009 | CN100526878C Method for detecting oral disintegration tablet for treating coronary heart disease |
| 08/12/2009 | CN100526471C Method for preparing avenin ACE inhibiting peptide |
| 08/12/2009 | CN100526307C Metalloproteinase inhibitors |
| 08/12/2009 | CN100526293C 2,5-dihydroxy benzenes sulfonic acid magnesium and hydrate thereof |
| 08/12/2009 | CN100525830C Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and prod |
| 08/12/2009 | CN100525825C 'Naoxinan' tablet in use for cardiovascular disease, cerebrovascular disease and preparation method |
| 08/12/2009 | CN100525815C A medicinal wine capable of treating multiple diseases |
| 08/12/2009 | CN100525813C Medicine and food dual purpose Chinese medicinal nutritive product for preventing and treating palmus and its manufacturing method |
| 08/12/2009 | CN100525812C Compound medicine preparation for treating hypertension, and its application |
| 08/12/2009 | CN100525809C Medicinal composition of milkvetch root, chinaroot greenbrier and Hong Jingtian and its making method |
| 08/12/2009 | CN100525807C Medicine for treating hemorrhoids and its preparing method |
| 08/12/2009 | CN100525802C Medicine for treating piles and its preparation |
| 08/12/2009 | CN100525792C Chinese medicine composition for treating angiitis and phlebitis |
| 08/12/2009 | CN100525781C American falx extract, medicinal composition containing it and its making method |
| 08/12/2009 | CN100525780C Compound breviscapine pills |
| 08/12/2009 | CN100525777C Depolymerization glycosaminoglycan extracted from sea cucumber composition and its preparation method and application |
| 08/12/2009 | CN100525776C Application of peracetyl pueraria in preparation of medicine for treating blood deficient cerebrovascular disease |
| 08/12/2009 | CN100525775C Pueraria root flavone self-microemulsified soft capsule and its preparing method |
| 08/12/2009 | CN100525774C DiAo Xinxuekang soft capsule and preparation process and use thereof |
| 08/12/2009 | CN100525772C Application of 20(S)-panaxcoside -Rg3 in preparation of medicine for treating or preventing high blood pressure |
| 08/12/2009 | CN100525768C Novel compounds |
| 08/12/2009 | CN100525766C (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation |
| 08/12/2009 | CN100525763C Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 08/12/2009 | CN100525761C Pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorders |
| 08/12/2009 | CN100525759C Ready-made medicine of traditional chinese medicine for treating ischemic cranial vascular disease |
| 08/12/2009 | CN100525654C Applacation of combination for preparation of beverage containing all kinds of essential fatty-acid and essential amino-cid |
| 08/12/2009 | CN100525631C Non invasive measurements of chemical substances |
| 08/11/2009 | US7572924 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/11/2009 | US7572920 Benzimidazole derivative and use as a II receptor antagonist |